Verrica Pharmaceuticals Inc (VRCA) stock news · rev $35.6M
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
This VRCA news page leads with what Verrica Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for VRCA yet. We will not pad this page with generic market recap.
Latest reported VRCA revenue for 2025-12-31 was $35.6M. Net income was -$17.9M. Revenue was up 370.2% from 2024-12-31 to 2025-12-31. VRCA currently screens at market cap $79.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VRCA stock page; for the tape open the quote page.
VRCA stock news FAQ
What are VRCA's latest revenue and net income?
Latest cached Verrica Pharmaceuticals Inc (VRCA) revenue for Dec 31, 2025 was $35.6M. Net income was -$17.9M. Statements: https://lician.com/financials/vrca
How did VRCA revenue change from the prior cached period?
Cached Verrica Pharmaceuticals Inc (VRCA) revenue was up 370.2% from $7.6M (Dec 31, 2024) to $35.6M (Dec 31, 2025). Statements: https://lician.com/financials/vrca
What is VRCA's market cap?
Verrica Pharmaceuticals Inc (VRCA) market cap is $79.7M on the latest cached fundamentals snapshot.
What kind of company is VRCA?
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Where is VRCA stock news listed?
Cached stock news for Verrica Pharmaceuticals Inc (VRCA) is listed at https://lician.com/news/vrca. Filings: https://lician.com/sec/vrca
Not investment advice.